Clinical Trial Update: A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports termination of a Phase I/II study of IXO with Bevacizumab in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• IXO

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED